Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease

ClinicalTrials.gov ID: NCT02531113

Public ClinicalTrials.gov record NCT02531113. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multi-Center, Open-Label Induction Trial With Extension Period to Access Endoscopic Improvement and Changes in Intestinal and Serum Biomarkers in Patients With Moderately to Severely Active Crohn's Disease Receiving Oral RPC1063 as Induction Therapy

Study identification

NCT ID
NCT02531113
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Celgene
Industry
Enrollment
69 participants

Conditions and interventions

Interventions

  • RPC1063 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 8, 2015
Primary completion
Sep 11, 2019
Completion
Nov 27, 2019
Last update posted
Jan 21, 2021

2015 – 2019

United States locations

U.S. sites
13
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
Adobe Clinical Research LLC Tucson Arizona 85712
Florida Center for Gastroenterology Largo Florida 33777
IMIC, Inc. Palmetto Bay Florida 33157
Atlanta Gastroenterology Specialists PC Suwanee Georgia 30024
DM Clinical Research Oak Lawn Illinois 60453-3767
Gastroenterology Associates LLC Baton Rouge Louisiana 70809
Chevy Chase Clinical Research Chevy Chase Maryland 20815
Ehrhardt Clinical Research LLC Belton Missouri 64012
UC Health Clinical Trials Office Cincinnati Ohio 45267
Ohio State University Clinical Trials Management Office Columbus Ohio 43210
Gastroenterology Associates of Orangeburg Orangeburg South Carolina 29118
Gastro One Germantown Tennessee 38138
San Antonio Gastroenterology San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02531113, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 21, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02531113 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →